Health
Pfizer-BioNTech COVID-19 Vaccine Achieves 100% Effectiveness in Adolescents – Contagionlive.com
The newest data for the real-world assessment show the mRNA vaccine provides greater immunogenicity in persons aged 12-15 years old than in young adults.
Pfizer-BioNTech COVID-19 vaccine BNT162b2 provided an observed vaccine efficacy of 100% among adolescents aged 12-15 years old after 7 days post-administration with the 2-dose product.
The new findings from an ongoing, placebo-controlled, observer-blinded assessment of the mRNA vaccine in adolescent patients suggest BNT162b2 provides an even greater immune response in the population than that observed in vaccinated young adults.
Led by Robert W. Frenck, Jr., MD, of the Cincinnati Childrens Hospital,…
-
Noosa News24 hours agoCar of missing woman found west of Brisbane
-
Noosa News23 hours agoCar discovered in search for missing mother Tayla Spies last seen in rural Queensland two months ago
-
Business22 hours agoHow your ASX shares may be impacted by US tariffs
-
Noosa News23 hours agoSunshine Coast police saturate roads and beaches this Easter